Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
ADMA Biologics shares 'in arbitrage territory,' says Jefferies » 12:16
09/30/20
09/30
12:16
09/30/20
12:16
ADMA

ADMA Biologics

$2.21 /

+ (+0.00%)

Jefferies analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$2.21 /

+ (+0.00%)

ADMA ADMA Biologics
$2.21 /

+ (+0.00%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
03/16/20 H.C. Wainwright
ADMA Biologics price target lowered to $12 from $14 at H.C. Wainwright
ADMA ADMA Biologics
$2.21 /

+ (+0.00%)

  • 07
    Feb
ADMA ADMA Biologics
$2.21 /

+ (+0.00%)

ADMA ADMA Biologics
$2.21 /

+ (+0.00%)

Options
Largest borrow rate increases among liquid names » 08:45
09/30/20
09/30
08:45
09/30/20
08:45
LMND

Lemonade

$49.44 /

-1.685 (-3.30%)

, JWN

Nordstrom

$11.78 /

-0.49 (-3.99%)

, ADMA

ADMA Biologics

$2.20 /

+0.02 (+0.92%)

, SOLO

ElectraMeccanica

$2.51 /

+0.01 (+0.40%)

, IDEX

Ideanomics

$0.91 /

-0.0462 (-4.83%)

, UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$20.01 /

-0.64 (-3.10%)

, SHLL

Tortoise Acquisition

$53.49 /

+5.61 (+11.72%)

, GME

GameStop

$10.35 /

+0.28 (+2.78%)

, ALT

Altimmune

$13.01 /

+0.75 (+6.12%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Lemonade (LMND) 20.34% +4.19, Nordstrom (JWN) 5.16% +0.97, Adma Biologics (ADMA) 3.01% +0.79, Electrameccanica Vehicles Corp (SOLO) 32.80% +0.52, Ideanomics (IDEX) 80.80% +0.49, ProShares Ultra VIX Short Term Futures (UVXY) 2.11% +0.41, Tortoise Acquisition Corp (SHLL) 18.72% +0.38, GameStop (GME) 39.60% +0.35, Direxion Daily S&P Bear (SPXS) 0.98% +0.24, and Altimmune (ALT) 1.97% +0.20.

ShowHide Related Items >><<
UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$20.01 /

-0.64 (-3.10%)

SOLO ElectraMeccanica
$2.51 /

+0.01 (+0.40%)

SHLL Tortoise Acquisition
$53.49 /

+5.61 (+11.72%)

LMND Lemonade
$49.44 /

-1.685 (-3.30%)

JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

IDEX Ideanomics
$0.91 /

-0.0462 (-4.83%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

ALT Altimmune
$13.01 /

+0.75 (+6.12%)

ADMA ADMA Biologics
$2.20 /

+0.02 (+0.92%)

LMND Lemonade
$49.44 /

-1.685 (-3.30%)

08/14/20 Morgan Stanley
Lemonade price target lowered to $70 from $91 at Morgan Stanley
07/27/20
Fly Intel: Top five analyst initiations
07/27/20 Oppenheimer
Lemonade initiated with a Perform at Oppenheimer
07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

08/26/20 Citi
Nordstrom price target lowered to $17 from $19 at Citi
08/19/20 KeyBanc
Nordstrom price target lowered to $30 from $48 at KeyBanc
08/14/20 Wedbush
Wedbush cautious on Nordstrom into upcoming Q2 earnings
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
ADMA ADMA Biologics
$2.20 /

+0.02 (+0.92%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
03/16/20 H.C. Wainwright
ADMA Biologics price target lowered to $12 from $14 at H.C. Wainwright
SOLO ElectraMeccanica
$2.51 /

+0.01 (+0.40%)

04/03/20 Benchmark
ElectraMeccanica downgraded to Speculative Hold at Benchmark
IDEX Ideanomics
$0.91 /

-0.0462 (-4.83%)

UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$20.01 /

-0.64 (-3.10%)

SHLL Tortoise Acquisition
$53.49 /

+5.61 (+11.72%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/23/20 Loop Capital
GameStop price target raised to $9 from $6 at Loop Capital
09/14/20
Fly Intel: Top five analyst upgrades
09/14/20 Jefferies
GameStop upgraded to Buy ahead of video game console cycle at Jefferies
ALT Altimmune
$13.01 /

+0.75 (+6.12%)

09/25/20 B. Riley Securities
Altimmune initiated with a Buy at B. Riley FBR
09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
08/25/20 Piper Sandler
Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler
LMND Lemonade
$49.44 /

-1.685 (-3.30%)

JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

ADMA ADMA Biologics
$2.20 /

+0.02 (+0.92%)

  • 14
    Jul
  • 02
    Jul
  • 07
    Feb
JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

IDEX Ideanomics
$0.91 /

-0.0462 (-4.83%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

SHLL Tortoise Acquisition
$53.49 /

+5.61 (+11.72%)

LMND Lemonade
$49.44 /

-1.685 (-3.30%)

JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

IDEX Ideanomics
$0.91 /

-0.0462 (-4.83%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

ALT Altimmune
$13.01 /

+0.75 (+6.12%)

ADMA ADMA Biologics
$2.20 /

+0.02 (+0.92%)

UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$20.01 /

-0.64 (-3.10%)

SOLO ElectraMeccanica
$2.51 /

+0.01 (+0.40%)

SHLL Tortoise Acquisition
$53.49 /

+5.61 (+11.72%)

LMND Lemonade
$49.44 /

-1.685 (-3.30%)

JWN Nordstrom
$11.78 /

-0.49 (-3.99%)

IDEX Ideanomics
$0.91 /

-0.0462 (-4.83%)

GME GameStop
$10.35 /

+0.28 (+2.78%)

ALT Altimmune
$13.01 /

+0.75 (+6.12%)

ADMA ADMA Biologics
$2.20 /

+0.02 (+0.92%)

Recommendations
Nu Skin price target raised to $60 from $57 at Jefferies » 08:11
09/30/20
09/30
08:11
09/30/20
08:11
NUS

Nu Skin

$48.92 /

-1.93 (-3.80%)

Jefferies analyst…

Jefferies analyst Stephanie Wissink raised the firm's price target on Nu Skin to $60 from $57 and keeps a Buy rating on the shares after increasing her estimates following talks with the company's President and CFO last week at the firm's Fitness & Wellness Summit. She believes the Q4 product launch of the ageLOC Boost skincare device is "under-modeled and under-guided," Wissink tells investors.

ShowHide Related Items >><<
NUS Nu Skin
$48.92 /

-1.93 (-3.80%)

NUS Nu Skin
$48.92 /

-1.93 (-3.80%)

09/11/20 Jefferies
Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies
08/06/20 Jefferies
Nu Skin price target raised to $57 from $50 at Jefferies
08/06/20 DA Davidson
Nu Skin price target raised to $61 from $54 at DA Davidson
08/06/20 Deutsche Bank
Nu Skin price target raised to $49 from $35 at Deutsche Bank
NUS Nu Skin
$48.92 /

-1.93 (-3.80%)

NUS Nu Skin
$48.92 /

-1.93 (-3.80%)

Yesterday
Initiation
Zynga started with a Buy rating at MKM Partners » 17:21
09/29/20
09/29
17:21
09/29/20
17:21
ZNGA

Zynga

$9.12 /

+0.05 (+0.55%)

As previously reported,…

As previously reported, MKM Partners analyst Eric Handler initiated coverage of Zynga with a Buy rating and $12 price target. The analyst said he likes Zynga for its leadership position in the mobile games space, the fastest growing segment within the video games industry. The company is well positioned to drive increases in bookings and adjusted EBITDA of 13% and 18%, respectively, between 2020-2023, Handler told investors in a research note. He cited organic growth, integration of the two recent acquisitions, steady margin improvement and ability to remain active with M&A as potential growth factors for the company going forward.

ShowHide Related Items >><<
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

09/29/20 MKM Partners
Zynga initiated with a Buy at MKM Partners
09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
08/19/20 Jefferies
Zynga remains Top Pick at Jefferies, sees a path to $13
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

  • 07
    Aug
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

Initiation
Zynga initiated with a Buy at MKM Partners » 16:16
09/29/20
09/29
16:16
09/29/20
16:16
ZNGA

Zynga

$9.12 /

+0.05 (+0.55%)

MKM Partners analyst Eric…

MKM Partners analyst Eric Handler initiated coverage of Zynga with a Buy rating and $12 price target.

ShowHide Related Items >><<
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
08/19/20 Jefferies
Zynga remains Top Pick at Jefferies, sees a path to $13
08/11/20
Fly Intel: Top five analyst downgrades
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

  • 07
    Aug
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

Options
Early notable gainers among liquid option names on September 29th » 09:55
09/29/20
09/29
09:55
09/29/20
09:55
TAP

Molson Coors

$34.55 /

+0.97 (+2.89%)

, WDC

Western Digital

$39.58 /

+0.97 (+2.51%)

, MU

Micron

$50.31 /

+0.58 (+1.17%)

, MAT

Mattel

$11.75 /

+0.35 (+3.07%)

, OKE

Oneok

$26.54 /

+0.54 (+2.08%)

Notable gainers among…

Notable gainers among liquid option names this morning include Molson Coors (TAP) $35.02 +1.44, Western Digital (WDC) $39.99 +1.35, Micron (MU) $51.20 +1.48, Mattel (MAT) $11.73 +0.34, and ONEOK (OKE) $26.57 +0.56.

ShowHide Related Items >><<
WDC Western Digital
$39.58 /

+0.97 (+2.51%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

OKE Oneok
$26.54 /

+0.54 (+2.08%)

MU Micron
$50.31 /

+0.58 (+1.17%)

MAT Mattel
$11.75 /

+0.35 (+3.07%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

07/15/20 Bryan Garnier
Molson Coors upgraded to Buy from Sell at Bryan Garnier
04/30/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/09/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/01/20 Goldman Sachs
Molson Coors resumed with a Sell at Goldman Sachs
WDC Western Digital
$39.58 /

+0.97 (+2.51%)

09/28/20 Deutsche Bank
Deutsche Bank closes 'Buy Catalyst Call' on Western Digital
09/23/20 Cleveland Research
Western Digital upgraded at Cleveland Research on improving demand outlooks
09/23/20 Cleveland Research
Western Digital upgraded to Neutral from Underperform at Cleveland Research
09/23/20 Craig-Hallum
Western Digital upgraded to Buy at Craig-Hallum
MU Micron
$50.31 /

+0.58 (+1.17%)

09/28/20 Citi
Citi opens 'Negative Catalyst Watch' on Micron ahead of results
09/23/20 Cleveland Research
Cleveland Research ups Micron to Buy ahead of expected bottom for DRAM and NAND
09/23/20 Cleveland Research
Micron upgraded to Buy from Neutral at Cleveland Research
09/14/20
Fly Intel: Top five analyst upgrades
MAT Mattel
$11.75 /

+0.35 (+3.07%)

07/24/20 MKM Partners
Mattel price target raised to $13 from $9 at MKM Partners
06/03/20
Fly Intel: Top five analyst upgrades
06/03/20 Jefferies
Jefferies upgrades Mattel to Buy with $13 price target
06/03/20 Jefferies
Mattel upgraded to Buy from Hold at Jefferies
OKE Oneok
$26.54 /

+0.54 (+2.08%)

09/29/20
Oneok upgraded to Buy at UBS on improving volume outlook
09/29/20 UBS
Oneok upgraded to Buy from Neutral at UBS
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Scotiabank
Oneok downgraded to Sector Perform with $31 target at Scotiabank
WDC Western Digital
$39.58 /

+0.97 (+2.51%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

OKE Oneok
$26.54 /

+0.54 (+2.08%)

MU Micron
$50.31 /

+0.58 (+1.17%)

MAT Mattel
$11.75 /

+0.35 (+3.07%)

  • 12
    Jun
WDC Western Digital
$39.58 /

+0.97 (+2.51%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

MU Micron
$50.31 /

+0.58 (+1.17%)

WDC Western Digital
$39.58 /

+0.97 (+2.51%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

OKE Oneok
$26.54 /

+0.54 (+2.08%)

MU Micron
$50.31 /

+0.58 (+1.17%)

MAT Mattel
$11.75 /

+0.35 (+3.07%)

WDC Western Digital
$39.58 /

+0.97 (+2.51%)

TAP Molson Coors
$34.55 /

+0.97 (+2.89%)

OKE Oneok
$26.54 /

+0.54 (+2.08%)

MU Micron
$50.31 /

+0.58 (+1.17%)

MAT Mattel
$11.75 /

+0.35 (+3.07%)

Monday
Hot Stocks
Roku says OS 9.4 to start rolling out to Roku devices in the coming weeks » 11:58
09/28/20
09/28
11:58
09/28/20
11:58
ROKU

Roku

$184.04 /

+1.6 (+0.88%)

Roku announced Roku OS…

Roku announced Roku OS 9.4 will start rolling out to Roku devices in the coming weeks. Roku OS 9.4 offers customers "new ways to access content quickly and a range of performance enhancements." The Roku Channel is adding more ways to access all-in-one entertainment via a new dedicated mobile app for iOS and Android smartphones available in the coming weeks, the company said. "The Roku OS allows consumers to easily get to the content they want to watch so they can sit back and enjoy the show," said Ilya Asnis, senior vice president of Roku OS at Roku. "With Roku OS 9.4, we give our customers even more choice and new ways to navigate and control content-rich experiences on and off Roku devices."

ShowHide Related Items >><<
ROKU Roku
$184.04 /

+1.6 (+0.88%)

ROKU Roku
$184.04 /

+1.6 (+0.88%)

09/28/20 KeyBanc
Apple content promotion shows importance of Roku's audience, says KeyBanc
09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
ROKU Roku
$184.04 /

+1.6 (+0.88%)

  • 17
    Mar
ROKU Roku
$184.04 /

+1.6 (+0.88%)

ROKU Roku
$184.04 /

+1.6 (+0.88%)

ROKU Roku
$184.04 /

+1.6 (+0.88%)

Hot Stocks
Roku unveils all new Roku Ultra, Roku Streambar » 11:57
09/28/20
09/28
11:57
09/28/20
11:57
ROKU

Roku

$184.21 /

+1.77 (+0.97%)

Roku unveiled its new…

Roku unveiled its new streaming lineup for the U.S. to include an all-new and redesigned Roku Ultra and the addition of the Roku Streambar. Roku Ultra offers the best performance of any Roku player for less than $100, and was specifically designed for avid streamers, the company said. For streamers looking to add powerful streaming and premium sound to any TV, the Roku Streambar is the easiest way for consumers to upgrade and de-clutter their home entertainment systems, Roku added. "We are focused on delivering a variety of innovative, top-performing products at an incredible value to our customers so they can get to the content they care about quickly," said Mark Ely, Vice President, Retail Product Strategy at Roku. "Our new streaming player lineup now includes reimagined streaming devices in the Roku Ultra and Roku Streambar - we continue to offer a great device no matter the use case our customers are looking for whether they are new to streaming or looking to add great sound and streaming to their home entertainment center."

ShowHide Related Items >><<
ROKU Roku
$184.21 /

+1.77 (+0.97%)

ROKU Roku
$184.21 /

+1.77 (+0.97%)

09/28/20 KeyBanc
Apple content promotion shows importance of Roku's audience, says KeyBanc
09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
ROKU Roku
$184.21 /

+1.77 (+0.97%)

  • 17
    Mar
ROKU Roku
$184.21 /

+1.77 (+0.97%)

ROKU Roku
$184.21 /

+1.77 (+0.97%)

ROKU Roku
$184.21 /

+1.77 (+0.97%)

Recommendations
Apple content promotion shows importance of Roku's audience, says KeyBanc » 10:42
09/28/20
09/28
10:42
09/28/20
10:42
ROKU

Roku

$185.75 /

+3.31 (+1.81%)

, AAPL

Apple

$113.85 /

+1.63 (+1.45%)

KeyBanc analyst Justin…

KeyBanc analyst Justin Patterson says that Roku's (ROKU) product and operating system updates this morning are consistent with the company's focus on enhancing performance, providing more ways to access content, and delivering innovative products at attractive price points. New devices ahead of the holiday season are not necessarily a surprise, however, the analyst is intrigued by a 3-month Apple (AAPL) TV+ credit for eligible purchases from October 23, 2020-January 31, 2021. Apple clearly has ambitions for both the living room and services, and certainly has a large base of iOS users to cross-sell, he contends In his view, Apple's willingness to promote content on Roku's platform demonstrates the importance of reaching Roku's audience of 40M-plus active accounts.

ShowHide Related Items >><<
ROKU Roku
$185.75 /

+3.31 (+1.81%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

ROKU Roku
$185.75 /

+3.31 (+1.81%)

09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
AAPL Apple
$113.85 /

+1.63 (+1.45%)

09/28/20 Northland
Identiv benefitting as Apple supports NFC, says Northland
09/25/20 Exane BNP Paribas
Exane double upgrades Qualcomm on share gains from Huawei ban
09/23/20 Jefferies
Facebook risk/reward 'remains compelling,' says Jefferies
09/22/20
UBS assumes Apple with Neutral from Buy amid 'maturing' iPhone growth
ROKU Roku
$185.75 /

+3.31 (+1.81%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

  • 17
    Mar
ROKU Roku
$185.75 /

+3.31 (+1.81%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

ROKU Roku
$185.75 /

+3.31 (+1.81%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

ROKU Roku
$185.75 /

+3.31 (+1.81%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

AAPL Apple
$113.85 /

+1.63 (+1.45%)

Options
Largest borrow rate increases among liquid names » 08:45
09/28/20
09/28
08:45
09/28/20
08:45
TAN

Claymore/MAC Global Solar Energy Index

$57.64 /

+1.86 (+3.33%)

, VBIV

VBI Vaccines

$3.07 /

+0.16 (+5.50%)

, CRBP

Corbus Pharmaceuticals

$1.56 /

+0.03 (+1.96%)

, AXU

Alexco Resource

$2.59 /

-0.105 (-3.90%)

, FIZZ

National Beverage

$70.06 /

+0.23 (+0.33%)

, CF

CF Industries

$30.42 /

-0.27 (-0.88%)

, PSTI

Pluristem

$9.66 /

+0.79 (+8.91%)

, MAXR

Maxar Technologies

$24.20 /

+0.515 (+2.17%)

, ADMA

ADMA Biologics

$2.18 /

+0.135 (+6.60%)

, XERS

Xeris Pharmaceuticals

$5.75 /

+0.19 (+3.42%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Guggenheim Global Solar Index (TAN) 8.88% +3.12, VBI Vaccines (VBIV) 18.89% +2.79, Corbus Pharmaceuticals (CRBP) 85.32% +0.95, Alexco Resource (AXU) 36.23% +0.66, National Beverage (FIZZ) 1.52% +0.41, CF Industries (CF) 0.49% +0.24, Pluristem (PSTI) 40.37% +0.22, Maxar Technologies (MAXR) 0.53% +0.18, Adma Biologics (ADMA) 2.20% +0.16, and Xeris Pharmaceuticals (XERS) 47.80% +0.16.

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

TAN Claymore/MAC Global Solar Energy Index
$57.64 /

+1.86 (+3.33%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 RBC Capital
Corbus Pharmaceuticals downgraded at RBC Capital after RESOLVE-1 study data
AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

05/18/20 Guggenheim
National Beverage price target raised to $38 from $34 at Guggenheim
11/18/19 Guggenheim
Coca-Cola's 'AHA' likely to take shelf space from LaCroix, says Guggenheim
11/11/19 Jefferies
National Beverage estimates and price target lowered at Jefferies
CF CF Industries
$30.42 /

-0.27 (-0.88%)

09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 HSBC
CF Industries downgraded to Hold from Buy at HSBC
09/15/20 Susquehanna
Deteriorating crop conditions positive for fertilizers, says Susquehanna
08/10/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

07/24/20 Jefferies
Pluristem price target raised to $16 from $12 at Jefferies
06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/19/20 Jefferies
Pluristem initiated with a Buy at Jefferies
04/24/20 H.C. Wainwright
Pluristem removed overhang with loan agreement, says H.C. Wainwright
MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

08/06/20 TD Securities
Maxar Technologies upgraded to Buy from Speculative Buy at TD Securities
06/24/20 JPMorgan
Maxar Technologies price target raised to $20 from $16 at JPMorgan
01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
01/08/20 JPMorgan
Maxar Technologies price target raised to $25 from $15 at JPMorgan
ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
03/16/20 H.C. Wainwright
ADMA Biologics price target lowered to $12 from $14 at H.C. Wainwright
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

  • 26
    Jun
  • 22
    Apr
  • 25
    Mar
  • 12
    Feb
  • 07
    Feb
  • 07
    Feb
VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

TAN Claymore/MAC Global Solar Energy Index
$57.64 /

+1.86 (+3.33%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.